Stock listing

NASDAQ:OVID Ovid Therapeutics Inc. Stock

Home listing (NASDAQ) of Ovid Therapeutics Inc.

Follow Ovid Therapeutics Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:OVID

$2.36 USD +0.19 (+8.8%)

Close on Oct 20, 2026

Past 3 months -9.6% · daily closes, Jul 6, 2026 – Oct 20, 2026, adjusted for splits
Day range
$2.18 – $2.46 USDOct 20, 2026
Volume
3.65M sharesOct 20, 2026
Market cap
$460.9M USDAt the close on Oct 20, 2026 · price × 195.3M shares outstanding
Ovid Therapeutics Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:OVID · Home$2.36 USD+0.19 (+8.8%)3,648,110$2.19$2.46$2.175$2.17Close on Oct 20, 2026
Frankfurt:1OT€2.08 EUR+0.16 (+8.3%)—€1.89€2.08€1.89€1.92Close on Oct 20, 2026

Daily closes

Last 3 months, Jul 20, 2026 – Oct 20, 2026 · NASDAQ:OVID · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$2.36+0.19+8.8%$2.19$2.46$2.1753,648,110
$2.17+0.02+0.9%$2.18$2.225$2.141,641,105
$2.15-0.11-4.9%$2.26$2.30$2.111,325,038
$2.26+0.07+3.2%$2.21$2.31$2.201,333,208
$2.190.000.0%$2.18$2.255$2.091,637,841
$2.19-0.22-9.1%$2.41$2.415$2.181,642,418
$2.41-0.05-2.0%$2.45$2.493$2.394875,520
$2.46+0.12+5.1%$2.37$2.475$2.331,406,717
$2.34-0.02-0.8%$2.32$2.36$2.291,649,253
$2.36-0.01-0.4%$2.36$2.46$2.341,003,730
$2.37+0.03+1.3%$2.42$2.44$2.271,735,000
$2.34-0.04-1.7%$2.38$2.47$2.291,192,400
$2.38-0.05-2.1%$2.47$2.48$2.332,173,400
$2.43-0.06-2.4%$2.49$2.53$2.421,349,500
$2.49-0.05-2.0%$2.54$2.605$2.481,442,400
$2.54+0.08+3.3%$2.47$2.54$2.421,163,600
$2.46+0.06+2.5%$2.40$2.49$2.351,192,400
$2.40-0.095-3.8%$2.49$2.51$2.401,364,800
$2.495-0.075-2.9%$2.54$2.54$2.4051,528,500
$2.57-0.19-6.9%$2.75$2.75$2.442,635,300
$2.76+0.05+1.8%$2.76$2.845$2.7143,742,800
$2.71+0.02+0.7%$2.73$2.76$2.651,183,000
$2.69-0.01-0.4%$2.68$2.73$2.635,899,300
$2.70+0.02+0.7%$2.73$2.77$2.661,985,800
$2.68-0.03-1.1%$2.72$2.765$2.651,428,000
$2.71-0.03-1.1%$2.73$2.745$2.63988,500
$2.74+0.05+1.9%$2.755$2.795$2.691,199,200
$2.69+0.06+2.3%$2.73$2.73$2.641,147,400
$2.63-0.07-2.6%$2.68$2.70$2.611,403,300
$2.70-0.05-1.8%$2.74$2.781$2.6851,263,800
$2.75-0.05-1.8%$2.75$2.81$2.731,150,400
$2.80+0.02+0.7%$2.74$2.825$2.711,066,000
$2.78+0.07+2.6%$2.80$2.83$2.731,361,900
$2.71-0.05-1.8%$2.78$2.87$2.681,555,900
$2.76+0.09+3.4%$2.65$2.78$2.641,294,900
$2.67-0.13-4.6%$2.78$2.805$2.651,392,600
$2.80-0.13-4.4%$2.87$2.93$2.761,673,700
$2.93+0.05+1.7%$2.85$2.95$2.831,722,000
$2.88-0.03-1.0%$2.905$2.93$2.8451,143,200
$2.91+0.09+3.2%$2.85$2.94$2.8151,449,582
$2.82+0.02+0.7%$2.79$2.86$2.671,230,370
$2.80+0.06+2.2%$2.76$2.83$2.711,331,900
$2.74-0.19-6.5%$2.88$2.93$2.721,146,500
$2.93+0.09+3.2%$2.90$2.95$2.842,875,500
$2.84-0.05-1.7%$2.87$2.905$2.7951,935,200
$2.89+0.06+2.1%$2.83$2.92$2.801,747,800
$2.83+0.03+1.1%$2.80$2.87$2.7451,240,900
$2.80+0.18+6.9%$2.65$2.875$2.622,242,800
$2.62+0.04+1.6%$2.44$2.645$2.43931,400
$2.58-0.04-1.5%$2.62$2.65$2.525903,202
$2.62-0.01-0.4%$2.59$2.62$2.531,252,320
$2.63-0.02-0.8%$2.69$2.69$2.60919,700
$2.65+0.03+1.1%$2.62$2.685$2.5851,294,400
$2.62+0.08+3.1%$2.52$2.68$2.492,253,500
$2.54+0.21+9.0%$2.33$2.555$2.331,666,200
$2.33+0.11+5.0%$2.222$2.36$2.2221,677,500
$2.22-0.15-6.3%$2.36$2.36$2.201,745,400
$2.37+0.08+3.5%$2.30$2.375$2.2751,286,400
$2.29-0.07-3.0%$2.35$2.40$2.255647,300
$2.36+0.01+0.4%$2.42$2.42$2.241,351,100
$2.35+0.02+0.9%$2.35$2.485$2.311,045,800
$2.33-0.07-2.9%$2.40$2.40$2.31984,900
$2.40+0.02+0.8%$2.36$2.43$2.294,728,300
$2.38-0.03-1.2%$2.518$2.518$2.331,086,600
$2.41+0.105+4.6%$2.30$2.435$2.291,779,600
$2.305-0.135-5.5%$2.42$2.47$2.301,283,600
Ticker
NASDAQ:OVID
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Calls

Replays

  • Ovid Therapeutics (NASDAQ:OVID) Q4 2025 Earnings Call

    Wed, Mar 18, 2026 · 8:30 AM ET

    Watch Transcript

Latest news

Ovid Therapeutics to Participate in Upcoming Investor Conferences

Sep 3, 2026

Closed $2.78 (+2.6%) on Sep 3, 2026

Ovid Therapeutics Reports Business Updates and Second Quarter 2026 Financial Results

Aug 13, 2026

Closed $2.80 (+6.9%) on Aug 13, 2026

Ovid Therapeutics Strengthens Executive Leadership Team to Support Continued Pipeline Progress and Next Phase of Development

Jul 8, 2026

Closed $2.73 (-1.1%) on Jul 8, 2026

Ovid Therapeutics Appoints Leading Physician-Scientist and Biotech Innovator Anna Greka, M.D., Ph.D., to Board of Directors

Jun 3, 2026

Ovid Therapeutics Reports Business Updates and First Quarter 2026 Financial Results

May 12, 2026

Ovid Therapeutics to Host Potassium-Chloride Co-transporter 2 (KCC2) Deep Dive R&D Event on Tuesday, April 14

Apr 8, 2026

Ovid Therapeutics Announces Pricing of $60 Million Private Placement

Mar 18, 2026

Ovid Therapeutics Announces New OV329 Data and Indication Expansion, Phase 1 Clearance for OV4071, and Reports Fourth Quarter and Full Year 2025 Financial Results

Mar 18, 2026

Ovid Therapeutics Reports Phase 1 results for the First-Ever Direct Activator of Potassium-Chloride Cotransporter 2, OV350 Intravenous

Dec 19, 2025

Ovid Therapeutics Reports Phase 1 Results for the First-Ever Direct Activator of Potassium-Chloride Cotransporter 2 (KCC2), OV350 Intravenous (IV)

Dec 18, 2025

All Ovid Therapeutics Inc. news

Decks

Ovid Therapeutics Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
14 in the last 12 months · 126 in all · newest Sep 3, 2026 · oldest 2019
Calls
1 call with a replay · 1 with a transcript · latest Mar 18, 2026
Decks
27 decks · latest Mar 18, 2026

Where Ovid Therapeutics Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:OVID · Home listing · This pageNASDAQUnited StatesUSD
gettex:1OTgettexGermanyEUR
LS Exchange:A2DQ8SLS ExchangeGermanyEUR
Lang & Schwarz:A2DQ8SLang & SchwarzGermanyEUR
BOATS:OVIDBOATSUnited StatesUSD
Tradegate:1OTTradegateGermanyEUR
Dusseldorf:1OTDusseldorfGermanyEUR
Frankfurt:1OTFrankfurtGermanyEUR
Hamburg:1OTHamburgGermanyEUR
Munich:1OTMunichGermanyEUR
Stuttgart:1OTStuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Ovid Therapeutics Inc.